This is a working overview of hGH fragment, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-09-21. Anything still debated is marked as such rather than presented as settled.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Peptide fragment | Corresponds to hGH residues 176-191 |
| Common synonyms | AOD9604, hGH 176-191 | Also written as AOD-9604 |
| Typical form | Lyophilized powder | Often supplied in sealed vials |
| Solubility | Water-soluble | Dissolves in aqueous buffers |
| Regulatory status | Not approved as drug | Banned in sport; varies by country |
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
=== Macronutrient ratios === The macronutrient ratios of low-carbohydrate diets are not standardized. As of 2018, the conflicting definitions of "low-carbohydrate" diets have complicated research into the subject. The National Lipid Association Nutrition and Lifestyle Task Force define low-carbohydrate diets and those containing less than 25% of calories from carbohydrates, and very low carbohydrate diets being those containing less than 10% carbohydrates. A 2016 review of low-carbohydrate diets classified diets with 50 g of carbohydrate per day (less than 10% of total calories) as "very low" and diets with 40% of calories from carbohydrates as "mild" low-carbohydrate diets. The UK National Health Service recommend that "carbohydrates should be the body's main source of energy in a healthy, balanced diet."
=== Response to pollution and environmental stress === Historical records indicate that X. parietina persisted in London despite severe air pollution, even when many other lichens disappeared. Mid-20th century mapping studies revealed that its distribution correlated with areas of moderate sulphur dioxide concentrations, but it was absent from the most polluted zones of central London, suggesting that while resistant to airborne contaminants, it has an upper tolerance limit. However, it is sensitive to certain pollutants, as demonstrated after the Torrey Canyon oil spill, when oil contamination and toxic dispersants caused widespread mortality on coastal rocks. Affected thalli lost their characteristic orange pigmentation, indicating chemical damage that interfered with enzymatic and protein activity, ultimately leading to detachment from the rock surface. The dispersant BP 1002, used during cleanup efforts, was later found to be highly toxic to marine life and coastal lichens. In X. parietina, its surfactant components disrupted algal cell membranes, reducing photosynthetic activity and accelerating thallus deterioration. Pollution affects both the population structure and development of X. parietina. There has been a decline in population density with increasing pollution levels; one study documented approximately 47 thalli per tree in lightly polluted zones, compared to 12 in moderately polluted areas and 9 in severely polluted regions. In unpolluted environments, the lichen completes its full life cycle, reaching maturity and old age.
Tissue engineering aims to replace lost or damaged tissues within the body. The success of such efforts has depended greatly upon the ability to direct cell behavior and encourage regeneration of tissues. A key method of doing so utilizes ECM-derived ligands such as RGD to control cellular responses to a biomaterial, such as attachment, proliferation, and differentiation.
The World Bektashi Congress, also called the National Congress of the Bektashi, a conference during which members of the Bektashi Community make important decisions, has been held in Albania several times. Since 1945, it has been held exclusively in Tirana. The longest gap between two congresses lasted from 1950 to 1993, when congresses could not be held during Communist rule in Albania. A list of congresses is given below.
Sources: en.wikipedia.org
===== Daniela Carneiro ===== In the same month Minister of Tourism Daniela Carneiro came under scrutiny for her association with individuals believed to command militias in Rio de Janeiro. Carneiro, a member of the Brazil Union party, had been included by the Lula government in the Ministry of Tourism in order to increase its alliance with parties of different political positions. According to a report by Veja, Daniela, the most voted federal deputy in Rio de Janeiro in 2022, was introduced to Lula by Washington Quaquá, coordinator of Lula's campaign in Rio, and was also chosen for other characteristics considered important for the PT: being a woman and evangelical. After the appointment of Daniela, previously known as Daniela do Waguinho, press outlets began publishing a series of reports showing involvement of Carneiro's political group with militias in the Baixada Fluminense, which had also previously shown involvement and links with other politicians from right-wing parties. On 3 January, g1 published a 2018 photo of Daniela alongside Juracy Alves Prudêncio, better known as Jura, a former military police sergeant identified as the leader of a militia responsible for killings in the Baixada Fluminense. Juracy appears in videos working as a campaign worker for her. He was sentenced to 26 years in prison for murder, moved to the semi-open prison regime in 2017, and went to work at the city hall of Belford Roxo, where the mayor was Wagner dos Santos Carneiro, known as Waguinho, Daniela's husband.
== External links == Clinical trial number (NCT05656027 for "Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia (CLARITY)" at ClinicalTrials.gov Clinical trial number (NCT05728944 for "Phase 3 Efficacy Study of LNZ101 for the Treatment of Presbyopia (CLARITY)" at ClinicalTrials.gov Clinical trial number (NCT05753189 for "Phase 3 Safety Study for the Treatment of Presbyopia Subjects" at ClinicalTrials.gov
Primary structure Elzinga and co-workers first determined the complete peptide sequence for this type of actin in 1973, with later work by the same author adding further detail to the model. It contains 374 amino acid residues. Its N-terminus is highly acidic and starts with an acetyled aspartate in its amino group, while its C-terminus is alkaline and is formed by a phenylalanine preceded by a cysteine, which has a degree of functional importance. Both extremes are in close proximity within the I-subdomain. An anomalous Nτ-methylhistidine is located at position 73.
Sources: en.wikipedia.org
== Detroit Lions == It has been said that Detroit Lions' announcer Van Patrick applied the nickname "Fearsome Foursome" to the Lions front four as early as 1960, when the Lion defensive line consisted of ends Bill Glass and Darris McCord, and tackles Alex Karras and Roger Brown. Other reports state that sportswriter Bruno Kerns of the Pontiac Press first used the Fearsome Four nickname for the Lions' defensive line in 1960. The Fearsome Foursome name for the Lions' defensive line continued after Sam Williams replaced Glass in 1962; Glass being traded to the Cleveland Browns for quarterback Milt Plum after the 1961 season. Other than 1963, McCord, Karras, Brown and Williams started together from 1962 through 1965; until Williams was taken by the Atlanta Falcons in the 1966 expansion draft. Karras missed the 1963 season as he was suspended in connection with alleged gambling. Their most well-known game was the 1962 "Thanksgiving Day Massacre" game against the Green Bay Packers, where they sacked Bart Starr 11 times (seven by Brown) and broke the Packers 12-game winning streak. The group's early defensive coordinator was future Pro Football Hall of Fame head coach Don Shula. Karras is in the Pro Football Hall of Fame. The 6 ft 5 in (1.96 m) 300 pound (136 kg) Brown, was one of the first NFL lineman to play at 300 pounds or more, with the speed and agility to make him highly effective at that weight. Brown was named to the Pro Bowl as a Lion from 1962 through 1966 and first-team All-Pro twice (1962-63).
=== Occurrence === Trace amounts of benzene are found in petroleum and coal. It is a byproduct of the incomplete combustion of many materials. For commercial use, until World War II, much of benzene was obtained as a by-product of coke production (or "coke-oven light oil") for the steel industry. However, in the 1950s, increased demand for benzene, especially from the growing polymers industry, necessitated the production of benzene from petroleum. Today, most benzene comes from the petrochemical industry, with only a small fraction being produced from coal. Benzene has been detected on Mars.
=== Depression === Characterized by loss of neuroplasticity, depression is a common mood disorder causing persistent negative emotions and changes in lifestyle. Intranasal delivery of relaxin-3 mimetics demonstrated significant anti-depressant activity in behavior paradigms of rat models. Delivering a thermoresponsive hydrogel loaded with berberine intranasally exhibited high bioavailability in hippocampus and anti-depressant activity.
Sources: en.wikipedia.org
AOD-9604 is a synthetic peptide fragment of human growth hormone, corresponding to amino acids 176-191. It is studied for potential effects on fat metabolism, but it is not approved as a drug in most countries. Its exact mechanism remains under investigation.
No, it is a small fragment of the full growth hormone protein. It does not appear to stimulate growth or increase growth hormone levels in the same way. Its actions are thought to be more limited to metabolic pathways.
Regulatory status varies. It is not approved for medical use in the United States or many other countries. It is banned in sport by WADA, and its sale as a supplement or research chemical may be subject to legal restrictions.
No, it is a synthetic peptide fragment corresponding to a small portion of hGH. It is not the full 191-amino-acid hormone and does not reproduce all of hGH's effects.